Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

110.67 +1.33 (+1.21%)
Delayed Quote Updated: 1:36 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 26.1% year on year to $186.7 million. The company’s... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know
A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index... 
Via StockStory
Topics Bonds Economy Stocks
News headline image
3 Unpopular Stocks We Find Risky
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Topics Economy
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
iRhythm Technologies Inc (NASDAQ:IRTC) Fits Mark Minervini’s Trend-Following Strategy with Strong Technicals and Growth Momentum ↗
iRhythm Technologies (IRTC) aligns with Mark Minervini's trend-following strategy, showing strong technicals, rising revenue, and earnings growth. A top performer in healthcare, IRTC is near its... 
Via Chartmill
News headline image
iRhythm (IRTC) Stock Trades Up, Here Is Why
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 18% in the morning session after the company reported strong second-quarter earnings that surpassed analyst expectations... 
Via StockStory
Topics Artificial Intelligence
News headline image
iRhythm (IRTC) Q2 Revenue Jumps 26% ↗
Via The Motley Fool
News headline image
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
iRhythm (IRTC) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Law Enforcement World Trade
News headline image
Breaking Down iRhythm Technologies: 4 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
iRhythm Technologies Inc (NASDAQ:IRTC) Q2 2025 Earnings: Revenue Beat and Narrower Loss Surprise Analysts ↗
iRhythm Technologies (IRTC) reported Q2 2025 revenue of $186.69M, beating estimates, with a narrower loss of -$0.32 EPS. Stock remained steady post-earnings. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
iRhythm (NASDAQ:IRTC) Delivers Strong Q2 Numbers, Stock Soars
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 26.1% year on year to $186.7 million. The company’s... 
Via StockStory
News headline image
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies Announces Second Quarter 2025 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
What To Expect From iRhythm’s (IRTC) Q2 Earnings
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results this Thursday after market hours. Here’s what to look for. 
Via StockStory
News headline image
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
1 Russell 2000 Stock Worth Your Attention and 2 Facing Challenges
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
News headline image
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
From iRhythm
Via GlobeNewswire
News headline image
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
1 Healthcare Stock on Our Buy List and 2 to Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
News headline image
iRhythm (IRTC) Stock Trades Up, Here Is Why
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.2% in the afternoon session after the positive sentiment from Wall Street analysts who saw further potential in the... 
Via StockStory
Topics Artificial Intelligence
News headline image
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
From iRhythm
Via GlobeNewswire
News headline image
Patient Monitoring Stocks Q1 In Review: iRhythm (NASDAQ:IRTC) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
1 Growth Stock with Impressive Fundamentals and 2 to Be Wary Of
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
News headline image
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major... 
From iRhythm
Via GlobeNewswire
News headline image
Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss
From Robbins LLP
Via GlobeNewswire
News headline image
3 Small-Cap Stocks Facing Headwinds
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
Expert Outlook: iRhythm Technologies Through The Eyes Of 6 Analysts ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.